Lonza Group AG 2022 AR2
The report highlights Lonza's strong performance in 2022, celebrating its 125th anniversary with CHF 6.2 billion in sales and 15.1% sales growth. The company made significant growth investments, including a CHF 500 million investment in a new large-scale commercial drug product facility in Stein, Switzerland. Lonza integrated ESG targets into its global remuneration programs and achieved key sustainability milestones, including a 13% reduction in greenhouse gas emissions intensity and a 13% reduction in water intensity compared to the previous year.
Company: Lonza Group AG
Sector: Manufacturing
Country: Switzerland
Year: 2022
Type: AR2
Pages: 234
Back to company
Lonza Group AG
Annual Report
The report highlights Lonza's strong performance in 2022, celebrating its 125th anniversary with CHF 6.2 billion in sales and 15.1% sales growth. The company made significant growth investments, including a CHF 500 million investment in a new large-scale commercial drug product facility in Stein, Switzerland. Lonza integrated ESG targets into its global remuneration programs and achieved key sustainability milestones, including a 13% reduction in greenhouse gas emissions intensity and a 13% reduction in water intensity compared to the previous year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Women on Board
Women in Management
Employees